STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Sera Prognostics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice (SERA) records a proposed sale of 222 Class A common shares through Morgan Stanley Smith Barney on 09/05/2025 with an aggregate market value of 744. The filing states these shares were acquired the same day via restricted stock unit vesting and lists total shares outstanding as 38,061,868. The filer disclosed three sales in the past three months by Mansoor Raza Mirza: 107 shares on 06/06/2025 for gross proceeds 169; 234 shares on 07/07/2025 for gross proceeds 552; and 225 shares on 08/05/2025 for gross proceeds 563. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR Routine Rule 144 notice for a small planned sale of vested restricted shares; standard seller attestation.

The filing documents a proposed sale of 222 Class A shares acquired by RSU vesting and slated to be sold via Morgan Stanley Smith Barney on 09/05/2025. The notice also discloses recent transactions by the same person totaling 566 shares over three months. The form includes the required attestation about absence of undisclosed material adverse information. From a compliance perspective, this is a standard execution of Rule 144 procedures.

TL;DR Small-volume insider sale notice with disclosed prior micro-sales; no financial performance data included.

The document provides transactional detail but no operational or financial metrics. It confirms acquisition via restricted stock unit vesting and identifies broker and planned sale date. Prior sales by Mansoor Raza Mirza are listed with quantities and gross proceeds. There is insufficient information here to assess market or company impact beyond the explicit transaction details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SERA Form 144 filed here report?

The filing reports a proposed sale of 222 Class A common shares to be executed on 09/05/2025 through Morgan Stanley Smith Barney with an aggregate market value of 744.

How were the 222 shares acquired according to the filing?

The filing states the shares were acquired on 09/05/2025 through Restricted Stock Unit vesting and the date of payment is listed as 09/05/2025.

What recent sales by the seller are disclosed in the filing?

Disclosed sales by Mansoor Raza Mirza in the past three months: 107 shares on 06/06/2025 (gross proceeds 169), 234 shares on 07/07/2025 (gross proceeds 552), and 225 shares on 08/05/2025 (gross proceeds 563).

Which broker is handling the proposed sale?

The proposed sale is to be handled by Morgan Stanley Smith Barney LLC (1 New York Plaza, 38th Floor, New York, NY 10004) and the securities exchange is listed as NASDAQ.

Does the filing include any statements about undisclosed material information?

Yes. The filer signs the standard representation that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

130.45M
33.40M
10.8%
64.96%
1.88%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY